Download Curriculum Vitae - Montana Cancer Center

Curriculum Vitae
Date Prepared: June 2010
Part I: General Information
Name:
Sarah M. Scott, MD
Office Address: PO Box 7877
Missoula, MT 59807-7877
Work Phone:
Work Fax:
Place of Birth:
(406)-728-2539
(406)-728 -2709
Newton, MA
Education:
1997
2003
B.S. (Biology) with High Honors; Dartmouth College
M.D.; University of Massachusetts Medical School
Postdoctoral Training:
2003–2004
2004–2006
2006–2007
2007–
Internship in Internal Medicine, Dartmouth Hitchcock Medical Center
Residency in Internal Medicine, Dartmouth Hitchcock Medical Center
Chief Medical Resident, Dartmouth Hitchcock Medical Center
Clinical Fellowship in Hematology/Oncology, Beth Israel Deaconess Medical Center
Licensure and Certification:
2004
2006
2005
2006
2006
2007
2007
American Heart Association, ACLS Certification
New Hampshire Registered Physician
United States Department of Justice Controlled Substances Registration
New Hampshire Controlled Substances Practitioner
Diplomat, American Board of Internal Medicine
Massachusetts Registered Physician
Massachusetts Controlled Substances Practitioner
Academic Appointments:
2003–2007
Instructor in Medicine, Dartmouth Hitchcock Medical Center, Dartmouth Medical
School, Hanover, NH
2007–2010
Clinical Fellow in Medicine, Division of Hematology/Oncology, Beth Israel Deaconess
Medical Center, Harvard Medical School, Boston, MA
Committee Service:
2006–2007
2006–2007
Intern Selection Committee, Dartmouth Hitchcock Medical Center
Chief Medical Resident Selection Committee, Dartmouth Hitchcock Medical Center
1
Professional Societies:
2003–
2003–
2007–
2009–
American College Of Physicians, Member
Massachusetts Medical Society, Member
American Society of Clinical Oncology, Associate Member
American Society of Hematology, Associate Member
Community Service Related to Professional Work:
1997–1999
2004–2007
Hospice Volunteer, Beth Israel Deaconess Palliative Care Center
Good Neighbor Health Clinic Volunteer Physician, Canaan, NH
Editorial Activities:
2006
Ad Hoc Reviewer, Journal of Clinical Endocrinology
Awards and Honors:
1997
2003
2004–2006
Christopher G. Reed Biologist Award, Dartmouth College
Alpha Omega Alpha Medical Honor Society, Dartmouth Medical School Chapter
Department of Internal Medicine Excellence in Teaching Award, Dartmouth Hitchcock
Medical Center
Part II: Research, Teaching, and Clinical Contributions
A. Narrative Report:
Following my graduation from the University of Massachusetts Medical School, I served as a medical
intern, medical resident, and chief medical resident at Dartmouth Hitchcock Medical Center. I then began
my clinical fellowship in hematology/oncology at Beth Israel Deaconess Medical Center, a major
teaching affiliate of Harvard Medical School. During my time at Beth Israel, I worked to develop my
clinical skills while engaging in opportunities to contribute to the education of Harvard medical students
and Beth Israel Deaconess residents and to pursue scholarly activities in the field of breast oncology.
Following my graduation from fellowship, I accepted a job at Montana Cancer Center in Missoula,
Montana, as a clinical hematologist/oncologist.
Unfunded Projects:
2007–2010
Co-investigator: Evaluation of patient and physician attitudes toward research biopsies
Report of Teaching
2002–2003
Physical Diagnosis, University of Massachusetts Medical School
Instructor
2007
2 medical students
Physical Diagnosis, Dartmouth Medical School
2
4 hours/week
Preceptor
2008
6 medical students
4 hours/week
Consult Fellow, Beth Israel Deaconess Medical Center
Supervisor
2 medical students
80 hours/week, 8 weeks
2 medical residents
2008
Inpatient Hematologic Malignancies Fellow, Beth Israel Deaconess Medical Center
Supervisor
3 medical interns
80 hours/week, 8 weeks
Clinical Supervisory and Training Responsibilities
2006–2007
Inpatient ward attending
2 medical residents
80 hours/week, 16 weeks
White River Junction VA Hospital, White River Junction, VT
2006–2007
Outpatient Clinic Supervisor 6 medical residents
Dartmouth Hitchcock Medical Center, Lebanon, NH
20 hours/week, 16 weeks
Invited Presentations
2006
Medical Grand Rounds, Dartmouth Hitchcock Medical Center
“MEN2A due to a unique C609S mutation presents with Pheochromocytoma and
Reduced Penetrance of Medullary Thyroid Carcinoma.”
2007
Tumor Board, Beth Israel Deaconess Medical Center
“Management of Testicular Seminoma.”
2007
Tumor Board, Beth Israel Deaconess Medical Center
“Cholangiocarcinoma: The case of a 48 yo man with back pain affecting his golf game.”
2007
Hematology Conference, Beth Israel Deaconess Medical Center
“Mycosis Fungoides: A case of papular pruritus with a poor prognosis.”
2007
Thoracic Oncology Tumor Board, Beth Israel Deaconess Medical Center
“Prophylactic Cranial Irradiation in Small-Cell Lung Cancer.”
2008
Tumor Board, Beth Israel Deaconess Medical Center
“Management of Thymoma and Thymic Carcinoma.”
2008
Tumor Board, Beth Israel Deaconess Medical Center
“Treatment of HER2–Positive Metastatic Breast Cancer: The case of a 63 yo woman
with an eight-month history of a painful breast mass.”
2008
Hematology Conference, Beth Israel Deaconess Medical Center
“Polycythemia Vera.”
3
2008
Thoracic Oncology Tumor Board, Beth Israel Deaconess Medical Center
“Large Cell Neuroendocrine Carcinoma.”
2008
Hematology Conference, Beth Israel Deaconess Medical Center
“Cases from the December consult service: “Heparin-induced thrombocytopenia.”
2009
Hematology Conference, Conference, Beth Israel Deaconess Medical Center
“Adult T-cell leukemia/lymphoma.”
2009
Clinical Journal Club, Beth Israel Deaconess Medical Center
“Endocrine therapy plus zoledronic acid in premenopausal breast cancer.”
2009
Hematology Conference, Beth Israel Deaconess Medical Center
“Cases from the June consult service: Hemophagocytic syndrome.”
2010
Clinical Journal Club, Beth Israel Deaconess Medical Center
“Lapatinib alone or in combination with trastuzumab in women with ErbB2-positive,
trastuzumab refractory metastatic breast cancer.”
2010
Hematology/Oncology Departmental Retreat, Beth Israel Deaconess Medical Center
“Tolerability and efficacy of 500mg fulvestrant in postmenopausal women with estrogenreceptor positive advanced breast cancer.”
2010
Hematology/Oncology Grand Rounds, Beth Israel Deaconess Medical Center
“Scholarly projects in breast oncology.”
Report of Clinical Activities
As a clinical fellow in hematology-oncology, I have cared for patients with a wide spectrum of
solid tumors and both benign and malignant hematologic diseases in both the inpatient and outpatient
settings. I am proficient in performing bone marrow aspirates and biopsies as well as lumbar punctures
with administration of intrathecal chemotherapy. Patient load 2007-2008: 30/week. Patient load 20082009: 10-15/week (reduced in the second year of fellowship to allow for research activities) and in 20092010: 30/week.
Part III: Bibliography
Completed manuscripts:
Review article: “A Reappraisal of Fulvestrant for the Treatment of Advanced Breast Cancer in Light of
Recent Data.” (Submitted to Cancer June 2010)
“Tolerability and efficacy of 500mg fulvestrant in post-menopausal women with estrogen-receptor
positive advanced breast cancer.” (Manuscript completed, pending submission)
Peer-reviewed article:
4
WB Kinlaw, SM Scott, RA Maue, VA Memoli, RD Harris, GH Daniels, DM Porter, DR Belloni, ET
Spooner, ET Ernesti, and WW Noll, “MEN2A Due to a Unique C609S Mutation Presents With
Pheochromocytoma and Reduced Penetrance of Medullary Thyroid Carcinoma,” Journal of Clinical
Endocrinology 63(6):676-682 (2005).
Other peer-reviewed publications:
Letter to the Editor
SM Scott and ZM Szczepiorkowski, “Rituximab for TTP,” American Journal of Hematology 80(1):87
(Sept. 2005).
Book Review
What Dying People Want: Practical Wisdom for the End of Life by David Kohl. Journal of Palliative
Medicine 2(2):326-327 (April 2004).
Honors Thesis:
“Investigation of the 5’AMP-Activated Protein Kinase As a Regulator of Gene Transcription and Glucose
Transport,” Senior Honors Thesis in Biology, Dartmouth College.
5